BX Swiss TOP 30 CHF
1.376,07
PKT
-0,66
PKT
-0,05
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 29.08.12 | Novartis neutral | Citigroup Corp. | |
| 29.08.12 | Swisscom buy | Société Générale Group S.A. (SG) | |
| 29.08.12 | ABB (Asea Brown Boveri) neutral | Exane-BNP Paribas SA | |
| 28.08.12 | Roche buy | Deutsche Bank AG | |
| 28.08.12 | Novartis buy | Deutsche Bank AG | |
| 28.08.12 | Novartis reduce | Vontobel Research | |
| 27.08.12 | Straumann reduce | Commerzbank Corp. & Markets | |
| 27.08.12 | Roche buy | Sarasin Research | |
| 27.08.12 | Novartis reduce | Vontobel Research | |
| 24.08.12 | Roche overweight | J.P. Morgan Cazenove | |
| 24.08.12 | Givaudan sell | Deutsche Bank AG | |
| 24.08.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 23.08.12 | Givaudan sell | Deutsche Bank AG | |
| 23.08.12 | UBS buy | Deutsche Bank AG | |
| 23.08.12 | Logitech outperform | Exane-BNP Paribas SA | |
| 22.08.12 | Straumann neutral | UBS AG | |
| 22.08.12 | Lindt neutral | UBS AG | |
| 22.08.12 | Straumann neutral | Nomura | |
| 22.08.12 | Straumann underperform | Cheuvreux SA | |
| 22.08.12 | Straumann underperform | Exane-BNP Paribas SA | |
| 22.08.12 | ABB (Asea Brown Boveri) sell | Deutsche Bank AG | |
| 22.08.12 | Lindt underperform | Cheuvreux SA | |
| 22.08.12 | Straumann hold | Vontobel Research | |
| 22.08.12 | Zurich Insurance buy | Vontobel Research | |
| 22.08.12 | Lindt hold | Vontobel Research | |
| 21.08.12 | Swiss Life neutral | J.P. Morgan Cazenove | |
| 21.08.12 | UBS halten | Norddeutsche Landesbank (Nord/LB) | |
| 21.08.12 | UBS halten | Norddeutsche Landesbank (Nord/LB) | |
| 21.08.12 | Zurich Insurance buy | Citigroup Corp. | |
| 21.08.12 | Swiss Life neutral | Goldman Sachs Group Inc. | |
| 21.08.12 | Straumann neutral | Sarasin Research | |
| 21.08.12 | Lindt neutral | Sarasin Research | |
| 21.08.12 | Lindt hold | Deutsche Bank AG | |
| 21.08.12 | Swiss Life buy | Deutsche Bank AG | |
| 21.08.12 | Julius Bär reduce | Vontobel Research | |
| 21.08.12 | Lindt hold | Vontobel Research | |
| 20.08.12 | Swiss Life neutral | J.P. Morgan Cazenove | |
| 20.08.12 | Novartis neutral | Goldman Sachs Group Inc. | |
| 20.08.12 | Swiss Life buy | Nomura | |
| 20.08.12 | Swiss Life buy | Vontobel Research |